APA (7th ed.) Citation

Chakrabarti, A., Shivaprakash, M. R., Curfs-Breuker, I., Baghela, A., Klaassen, C. H., & Meis, J. F. (2010). Apophysomyces elegans: Epidemiology, amplified fragment length polymorphism typing, and in vitro antifungal susceptibility pattern. Journal of clinical microbiology, 48(12), 4580. https://doi.org/10.1128/JCM.01420-10

Chicago Style (17th ed.) Citation

Chakrabarti, A., M R. Shivaprakash, I. Curfs-Breuker, A. Baghela, C H. Klaassen, and J F. Meis. "Apophysomyces Elegans: Epidemiology, Amplified Fragment Length Polymorphism Typing, and in Vitro Antifungal Susceptibility Pattern." Journal of Clinical Microbiology 48, no. 12 (2010): 4580. https://doi.org/10.1128/JCM.01420-10.

MLA (9th ed.) Citation

Chakrabarti, A., et al. "Apophysomyces Elegans: Epidemiology, Amplified Fragment Length Polymorphism Typing, and in Vitro Antifungal Susceptibility Pattern." Journal of Clinical Microbiology, vol. 48, no. 12, 2010, p. 4580, https://doi.org/10.1128/JCM.01420-10.